Targeting RNA with small molecules

ChemBioChem

Volumn 4, Issue 10, 2003, Pages 998-1007

  Tor, Yitzhak ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aminoglycosides; Antibiotics; HIV; RNA; RNA recognition

Indexed keywords

2'' DEOXYTOBRAMYCIN; 4 DEOXYTOBRAMYCIN; 4'' DEOXYTOBRAMYCIN; 6'' AMINO 6'' DEOXYKANAMYCIN A; 6'' AMINOKANAMYCIN A; 6'' DEOXYTOBRAMYCIN; ACRIDINE DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BEO S ACRIDINE; GLYCOSIDE; GUANIDINOGLYCOSIDE; HAMMERHEAD RIBOZYME; KANAMYCIN A; KANAMYCIN B; LIGAND; NEO C ACRIDINE; NEO N ACRIDINE; REV PROTEIN; RIBOZYME; RNA; TOBRAMYCIN; TOBRAMYCIN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIVIRAL ACTIVITY; BINDING AFFINITY; BIOASSAY; CELL FUNCTION; CHEMICAL MODIFICATION; DNA RESPONSIVE ELEMENT; DRUG BINDING; ELECTRICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MODEL; MOLECULAR RECOGNITION; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REV RESPONSIVE ELEMENT; RNA BINDING; SHORT SURVEY; SMALL MOLECULE; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; ELECTROSTATICS; KANAMYCIN; MODELS, MOLECULAR; RNA; RNA, CATALYTIC; RNA, RIBOSOMAL; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0142011647     PISSN: 14394227     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbic.200300680     Document Type: Short Survey

References (108)

1. H. F. Judson, The Eighth Day of Creation, Simon & Schuster, New York, 1980.
2. a) K. Kruger, K. P. J. Grabowski, A. J. Zaug, J. Sands, D. E. Gottschling, T. R. Cech, Cell 1982, 31, 147-157;
3. b) T. R. Cech, Annu. Rev. Biochem. 1990, 59, 543-568.
4. C. Guerrier-Takada, K. Gardiner, T. Marsh, N. Pace, S. Altman, Cell 1983, 35, 849-857.
5. J. A. Doudna, T. R. Cech, Nature 2002, 418, 222-228.
6. a) J. Harms, F. Schluenzen, R. Zarivach, A. Bashan, S. Gat, I. Agmon, H. Bartels, F. Franceschi, A. Yonath, Cell 2001, 107, 679-688;
7. b) A. Yonath, Annu. Rev. Biophys. Biomol. Struc. 2002, 31, 257-273;
8. c) A. Bashan, I. Agmon, R. Zarivach, F. Schluenzen, J. Harms, R. Berisio, H. Bartels, F. Franceschi, T. Auerbach, H. A. S. Hansen, E. Kossoy, M. Kessler, A. Yonath, Mol. Cell 2003, 11, 91-102.
9. a) B. T. Wimberly, D. E. Brodersen, W. M. Clemons, Jr., R. J. Morgan-Warren, A. P. Carter, C. Vonrhein, T. Hartsch, V. Ramakrishnan, Nature 2000, 407, 327-339;
10. b) V. Ramakrishnan, Cell 2002, 108, 557-572.
11. M. M. Yusupov, G. Zh. Yusupova, A. Baucom, K. Lieberman, T. N. Earnest, J. H. D. Cate, H. F. Noller, Science 2001, 292, 883-896.
12. N. Ban, P. Nissen, J. Hansen, P. B. Moore, T. A. Steitz, Science 2000, 289, 902-921;
13. b) P. B. Moore, T. A. Steitz, Nature 2002, 418, 229-235.
14. G. J. Hannon, Nature 2002, 418, 244-251.
15. a) W. Winkler, A. Nahvi, R. R. Breaker, Nature 2002, 419, 952-956;
16. b) A, Nahvi, N. Sudarsan, M. S. Ebert, X. Zou, K. L. Brown, R. R. Breaker, Chem. Biol. 2002, 9, 1043-1049.
17. See also: G. Werstuck, M. R. Green, Science 1998, 282, 296-298.
18. Y. Tor, Angew. Chem. 1999, 111, 1681-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
19. Y. Tor, Angew. Chem. 1999, 111, 1681-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
20. a) M. G. Wallis, R. Schroeder, Prog. Biophys. Molec. Biol. 1997, 67, 141-154;
21. b) R. Schroeder, C. Waldsich, H. Wank, EMBO J. 2000, 19, 1-9.
22. C. S. Chow, F. M. Bogdan, Chem. Rev. 1997, 97, 1489-1513.
23. N. D. Pearson, C. D. Prescott, Chem. Biol. 1997, 4, 409-414.
24. T. Hermann, E. Westhof, Biopolymers 1998, 48, 155-165.
25. a) T. Hermann, E. Westhof, Curr. Opin. Biotech. 1998, 9, 66-73;
26. b) T. Hermann, E. Westhof, Comb. Chem. High Through. Screen. 2000, 3, 219-234;
27. c) T. Hermann, D. J. Patel, Science 2000, 287, 820-825.
28. a) D. J. Ecker, R. H. Griffey, Drug Discovery Today 1999, 4, 420-429;
29. b) S. A. Hofstadler, R. H. Griffey, Chem. Rev. 2001, 101, 377-390;
30. c) R. H. Griffey, E. E. Swayze, Expert Opinion on Therapeutic Patents 2002, 12, 1367-1374.
31. a) P. Sears, C.-H. Wong, Chem. Commun. 1998, 11, 1161-1170;
32. b) S. J. Sucheck, C.-H. Wong, Curr. Opin. Chem. Biol. 2000, 4, 678-686;
33. c) T. K. Ritter, C.-H. Wong, Angew. Chem. 2001, 113, 3616-3641; Angew. Chem. Int. Ed. 2001, 40, 3508-3533;
34. c) T. K. Ritter, C.-H. Wong, Angew. Chem. 2001, 113, 3616-3641; Angew. Chem. Int. Ed. 2001, 40, 3508-3533;
35. d) C.-H. Wong, M. C. Bryan, P. T. Nyffeler, H. Liu, E. Chapman, Pure Appl. Chem. 2003, 75, 179-186.
36. a) W. D. Wilson, K. Li, Curr. Med. Chem. 2000, 7, 73-98;
37. b) T. M. Davis, W. D. Wilson, Methods in Enzymology 2001, 340, 22-51.
38. a) T. Hermann, Angew. Chem. 2000, 112, 1962-1979; Angew. Chem. Int. Ed. 2000, 39, 1891-1905;
39. a) T. Hermann, Angew. Chem. 2000, 112, 1962-1979; Angew. Chem. Int. Ed. 2000, 39, 1891-1905;
40. b) T. Hermann, Biochimie 2002, 84, 869-875.
41. J. Gallego, G. Varani, Acc. Chem. Res. 2001, 34, 836-843.
42. I. R. Hooper, in Aminoglycosides Antibiotics. Handbook of Experimental Pharmacology (Eds.: S. Umezawa, I. R. Hooper), Springer, New York, 1982, Vol 62, pp. 1-35.
43. Goodman & Gilman's The Pharmacological Basis of Therapeutics (Eds.: J. G. Hardman, L. E. Limbird), McGraw-Hill, 9th ed, 1996, pp. 1103-1121.
44. A. Schatz, E. Bugle, 5. A. Waksman, Proc. Soc. Exp. Biol. Med. 1944, 55, 66-69.
45. J. Davies, W. Gilbert, L. Gorini, Proc. Natl. Acad. Sci. USA 1964, 51, 883-890.
46. D. Moazed, H. F. Noller, Nature 1987, 327, 389-394.
47. U. von Ahsen, J. Davies, R. Schroeder, Nature 1991, 353, 368-370.
48. M. L. Zapp, S. Stern, M. R. Green, Cell 1993, 74, 969-978.
49. For an early review, see K. Michael, Y. Tor, Chem. Eur. J. 1998, 4, 2091-2098.
50. K. Michael, Y. Tor in Molecular Biology Intelligence Unit 2001, 73, 130-145.
51. O.C. Uhlenbeck, Nature 1987, 328, 596-600.
52. N. K. Vaish, A. R. Kore, F. Eckstein, Nucl. Acids Res. 1998, 26, 5237-242.
53. K. R. Birikh, P. A. Heaton, F. Eckstein, Eur. J. Biochem. 1997, 245, 1-16.
54. S. Verma, N. K. Vaish, F. Eckstein, Curr. Opin. Chem. Biol. 1997, 1, 532-536.
55. J. E. Wedekind, D. B. McKay, Annu. Rev. Biophys. Biomol. Struct. 1998, 27, 475-502.
56. D. M. Zhou, K. Taira, Chem. Rev. 1998, 98, 991-1026.
57. M. Amarzguioui, H. Prydz, Cell. Mol. Life Sci. 1998, 54, 1175-1202.
58. T. K. Stage, K. J., Hertel, O. C. Uhlenbeck, RNA 1995, 1, 95-101.
59. B. Clouet-d'Orval, T. K. Stage, O. C. Uhlenbeck, Biochemistry 1995, 34, 11186-11190.
60. See also: S. R. Kirk, N. W. Luedtke, Y. Tor, Bioorg. Med. Chem. 2001, 9, 2295-2301.
61. H. Wang, Y. Tor, J. Am. Chem. Soc. 1997, 119, 8734-8735.
62. a) D. E. Dorman, J. W. Paschal, K. E. Merkel, J. Am. Chem. Soc. 1976, 98, 6885-6888;
63. b) R. E. Botto, B. Coxon, J. Am. Chem. Soc. 1983, 105, 1021-1028;
64. c) L. Szilágyi, Z. Sz. Pusztahelyi, S. Jakab, I. Kovács, Carbohyd. Res. 1993, 247, 99-109.
65. For thorough biophysical studies of aminoglycoside-RNA binding, see a) M. Kaul, D. S. Pilch, Biochemistry 2002, 41, 7695-7706;
66. b) E. Jin, V. Katritch, W. K. Olson, M. Kharatisvili, R. Abagyan, D. S. Pilch, J. Mol. Biol. 2000, 298, 95-110;
67. c) D. S. Pilch, M. Kaul, C. M. Barbieri, J. E. Kerrigan, Biopolymers/Nucleic Acid Sciences 2003, 70, 58-79.
68. H. Wang, Y. Tor, Angew. Chem. 1998, 110, 117-120; Angew. Chem. Int. Ed. 1998, 37, 109-111.
69. H. Wang, Y. Tor, Angew. Chem. 1998, 110, 117-120; Angew. Chem. Int. Ed. 1998, 37, 109-111.
70. T. Hermann, E. Westhof, J. Mol. Biol. 1998, 276, 903-912.
71. Y. Tor, T. Hermann, E. Westhof, Chem. Biol. 1998, 5, R277-R283.
72. T. Hermann, E. Westhof, J. Med. Chem. 1999, 42, 1250-1261.
73. H. Wang, Y. Tor, Bioorg. Med. Chem. Lett. 1997, 7, 1951-1956.
74. H. Wang, Y. Tor, Bioorg. Med. Chem. Lett. 1998, 8, 3665-3670.
75. W. Saenger in Principles of Nucleic Acids Structure, Springer, NY, 1980, pp. 331-349.
76. S. R. Kirk, Y. Tor, Bioorg. Med. Chem. 1999, 7, 1979-1991.
77. N. E. Mikkelsen, K. Johansson, A. Virtanen, L.A. Kirsebom, Nature Struc. Biol. 2001, 8, 510-514.
78. H. Wang, Ph. D. Thesis, The University of California, San Diego, 1998.
79. K. Michael, H. Wang, Y. Tor, Bioorg. Med. Chem. 1999, 7, 1361-1371.
80. B. N. Fields, D. M. Knipe, P. M. Howley, Fundamental Virology, Third Edition, Lippincott-Raven, Philadelphia, 1996.
81. a) A. D. Frankel, J. A. T. Young, Ann. Rev. Biochem. 1998, 67, 1-25;
82. b) B. G. Turner, M. F. Summers, J. Mol. Biol. 1999, 285, 1-32.
83. a) C. A. Rosen, G. N. Pavlakis, AIDS 1990, 4, 499-509;
84. b) T. M. Rana, K.-T. Jeang, Archiv. Biochem. Biophys. 1999, 365, 175-185;
85. c) M. Emerman, M. H. Malim, Science 1998, 280, 1880-1884.
86. a) Y. N. Vaishnav, F. Wong-Staal, Annu. Rev. Biochem. 1991, 60, 577-630;
87. b) V. W. Pollard, M. H. Malim, Annu. Rev. Microbiol. 1998, 52, 491-532;
88. c) T. J. Hope, Archiv. Biochem. Biophys. 1999, 365, 186-191.
89. N. W. Luedtke, Y. Tor, Angew. Chem. 2000, 112, 1858-1860; Angew. Chem. Int. Ed. 2000, 39, 1788-1790.
90. N. W. Luedtke, Y. Tor, Angew. Chem. 2000, 112, 1858-1860; Angew. Chem. Int. Ed. 2000, 39, 1788-1790.
91. N. W. Luedtke, Y. Tor, Biopolymers/Nucleic Acid Sciences 2003, 70, 103-119.
92. A. Friedler, D. Friedler, N. W. Luedtke, Y. Tor, A. Loyter, C. Gilon, J. Biol. Chem. 2000, 275, 23783-23789.
93. N. W. Luedtke, J. S. Hwang, E. C. Glazer, D. Gut, M. Kol, Y. Tor, ChemBioChem. 2002, 3, 766-771.
94. J. L. Battiste, H. Mao, N. S. Rao, R. Tan, D. R. Muhandiram, L.E. Kay, A. D. Frankel, J. R. Williamson, Science, 1996, 273, 1547-1551.
95. S. R. Kirk, N. W. Luedtke, Y. Tor, J. Am. Chem. Soc. 2000, 122, 980-981.
96. N. W. Luedtke, Q. Liu, Y. Tor, Biochemistry 2003, in press.
97. M. A. Weiss, N. Narayana, Biopolymers/Nucleic Acid Sciences 1999, 48, 167-180.
98. N. W. Luedtke, T. J. Baker, M. Goodman, Y. Tor, J. Am. Chem. Soc. 2000, 122, 12035-12036.
99. T. J. Baker, N. W. Luedtke, Y. Tor, M. Goodman, J. Org. Chem. 2000, 65, 9054-9058.
100. N. W. Luedtke, P. Carmichael, Y. Tor, J. Am. Chem. Soc. 2003, in press.
101. Goodman & Gilman's The Pharmacological Basis of Therapeutics (Eds.: J. G. Hardman, L. E. Limbird), McGraw-Hill. 9th ed, 1996.
102. Y. Tor, Angew. Chem. 1999, 111, 1168-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
103. Y. Tor, Angew. Chem. 1999, 111, 1168-1685; Angew. Chem. Int. Ed. 1999, 38, 1579-1582.
104. E. Cundliffe, The Ribosome: Structure, Function and Evolution (Eds.: W. E. Hill, A. Dahlberg, R. A. Garrett, R B. Moore, D. Schlessinger, J. R. Warner), American Society of Microbiology, Washington, D.C., 1990, pp. 479-490.
105. For recent high resolution structures of ribosomal particles with antibiotics, see a) F. Schlunzen, R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, F. Franceschl, Nature 2001, 413, 814-821;
106. b) F. Schlunzen, J. M. Harms, F. Franceschi, H. A. S. Hansen, H. Bartels, R. Zarivach, A. Yonath, Structure 2003, 11, 329-338.
107. "Entering an unexplored world: RNA targeting", January 23-25, 2003, Wiesbaden, Germany.
108. E. F. Gale in Biochemical Studies of Antimicrobial Drugs, Cambridge University Press, Cambridge, 1966, pp. 1-21.